REQUEST A DEMO
Total
USD $0.00
Search more companies

Home Pharma Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Home Pharma Sas Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Home Pharma Sas is an enterprise based in Colombia. Its main office is in Barranquilla. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Home Pharma Sas was incorporated on August 01, 2019. Home Pharma Sas currently employs 50 (2023) people. From the latest financial highlights, Home Pharma Sas reported a net sales revenue increase of 179.17% in 2023. There was a total growth of 111.24% in Home Pharma Sas’s total assets over the same period. The net profit margin of Home Pharma Sas decreased by 5.53% in 2023.

Headquarters
Via 40 # 71-197 Bg 205B
Barranquilla; Atlantico;

Contact Details: Purchase the Home Pharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Home Pharma Sas report to view the information.
Outstanding Shares:
Purchase the Home Pharma Sas report to view the information.
Incorporation Date:
August 01, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Home Pharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
179.17%
Total operating revenue
179.17%
Operating profit (EBIT)
45.2%
Net Profit (Loss) for the Period
45.2%
Total assets
111.24%
Total equity
56.89%
Operating Profit Margin (ROS)
-5.53%
Net Profit Margin
-5.53%
Return on Equity (ROE)
-3.11%
Quick Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?